Gene therapy targeting amyloid pathology and neurodegeneration in Down syndrome

Innovative gene therapy using antisense oligonucleotides to target and normalize specific proteins associated with Alzheimer's Disease in individuals with Down Syndrome, aiming to delay or prevent the disease progression...